We are live on !
Find out more
New England Professional Planning Group Portfolio holdings
AUM
$263M
Turnover
5.88%
1-Year Est. Return
13.79%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+13.79%
3 Year Est. Return
+64.13%
5 Year Est. Return
+53.17%
10 Year Est. Return
–
AUM
$263M
AUM Growth
-$4.81M
(-1.8%)
Cap. Flow
-$1.71M
Cap. Flow % of AUM
Cap. Flow %
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
93.08%
Holding
51
New
1
Increased
9
Reduced
6
Closed
2
Avg Time Held
5
years
Top 10 Avg Time Held
4.1
years
Top 20 Avg Time Held
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.05M |
| 2 |
Merck
MRK
|
+$207K |
| 3 |
Raymond James Financial
RJF
|
+$25.9K |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$18.7K |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$1.33K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$1.6M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$394K |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$337K |
| 4 |
GE Vernova
GEV
|
+$247K |
| 5 |
IBM
IBM
|
+$239K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.15% |
| 2 | Financials | 3.65% |
| 3 | Technology | 1.83% |
| 4 | Industrials | 0.95% |
| 5 | Healthcare | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
iShares Core S&P 500 ETF
IVV
$847B
| $97M | 36.86% |
126,635
-220
| -0.2% | -$168K |
2015 Q3
44 quarters
|
|
|
2
JPMorgan International Research Enhanced Equity ETF
JIRE
$10.8B
| $61M | 23.19% |
742,797
-19,112
| -3% | -$1.6M |
2024 Q3
8 quarters
|
|
|
3
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $47.8M | 18.15% |
663,896
-5,225
| -0.8% | -$394K |
2015 Q3
44 quarters
|
|
|
4
iShares Core S&P Small-Cap ETF
IJR
$103B
| $23.8M | 9.06% |
175,157
-2,332
| -1% | -$337K |
2015 Q3
44 quarters
|
|
|
5
Raymond James Financial
RJF
$31.3B
| $7.45M | 2.83% |
47,150
+151
| +0.3% | +$25.9K |
2014 Q4
47 quarters
|
|
6
iShares Core MSCI Total International Stock ETF
IXUS
$55.9B
| $2.16M | 0.82% |
22,709
-14
| -0.1% | -$1.34K |
2015 Q3
44 quarters
|
|
|
7
Pfizer
PFE
$168B
| $1.67M | 0.63% |
58,572
+39,405
| +206% | +$1.05M |
2014 Q4
47 quarters
|
|
8
Apple
AAPL
$4.98T
| $1.62M | 0.62% |
4,860
| – | – |
2014 Q4
47 quarters
|
|
9
ExxonMobil
XOM
$677B
| $1.22M | 0.47% |
7,519
| – | – |
2014 Q4
47 quarters
|
|
10
Vanguard Total World Stock ETF
VT
$78.7B
| $1.2M | 0.45% |
7,574
| – | – |
2016 Q1
42 quarters
|
|
11
Union Pacific
UNP
$172B
| $1.1M | 0.42% |
4,047
| – | – |
2014 Q4
47 quarters
|
|
|
12
Vanguard Morningstar Total Stock Market ETF
VTI
$667B
| $1.07M | 0.41% |
2,854
+50
| +2% | +$18.7K |
2019 Q4
27 quarters
|
|
13
iShares Silver Trust
SLV
$25.2B
| $969K | 0.37% |
17,774
| – | – |
2021 Q1
22 quarters
|
|
14
iShares Russell 2000 ETF
IWM
$74.2B
| $936K | 0.36% |
3,367
+1
| +0% | +$294 |
2020 Q2
25 quarters
|
|
|
15
iShares MSCI USA Quality Factor ETF
QUAL
$11.8B
| $900K | 0.34% |
16,204
+24
| +0.1% | +$1.33K |
2020 Q1
26 quarters
|
|
16
iShares Russell Mid-Cap ETF
IWR
$56.8B
| $860K | 0.33% |
8,063
+5
| +0.1% | +$553 |
2020 Q1
26 quarters
|
|
17
NVIDIA
NVDA
$4.51T
| $753K | 0.29% |
3,299
| – | – |
2024 Q1
10 quarters
|
|
18
iShares Russell 1000 Growth ETF
IWF
$114B
| $716K | 0.27% |
5,720
| – | – |
2024 Q2
9 quarters
|
|
19
iShares MSCI ACWI ex US ETF
ACWX
$17.4B
| $666K | 0.25% |
8,801
| – | – |
2020 Q1
26 quarters
|
|
20
Cisco
CSCO
$370B
| $640K | 0.24% |
5,945
| – | – |
2020 Q4
23 quarters
|
|
21
Analog Devices
ADI
$176B
| $568K | 0.22% |
1,432
| – | – |
2021 Q3
20 quarters
|
|
22
Broadcom
AVGO
$1.4T
| $546K | 0.21% |
1,556
| – | – |
2024 Q1
10 quarters
|
|
23
Invesco S&P 500 High Beta ETF
SPHB
$754M
| $545K | 0.21% |
3,619
+4
| +0.1% | +$587 |
2021 Q1
22 quarters
|
|
24
Berkshire Hathaway Class B
BRK.B
$1.22T
| $544K | 0.21% |
1,092
| – | – |
2022 Q4
15 quarters
|
|
25
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $481K | 0.18% |
631
| – | – |
2021 Q1
22 quarters
|
|
Similar funds
BCM
New England Professional Planning Group's Q3 2026 Portfolio in Review
As of Q3 2026, New England Professional Planning Group held 51 positions worth $263M, down 1.8% from $268M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
New England Professional Planning Group's Q3 2026 filing shows 1 new, 9 increased, 6 reduced and 2 closed positions. Its largest new stake was Merck: 1,500 shares worth $218K. The largest sale was JPMorgan International Research Enhanced Equity ETF, an estimated $1.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Financials and Technology.
- New England Professional Planning Group's largest Q3 2026 buy was Merck: 1,500 shares worth $218K.
- New England Professional Planning Group added most to Pfizer in Q3 2026, an estimated $1.05M increase.
- New England Professional Planning Group's biggest Q3 2026 reduction was JPMorgan International Research Enhanced Equity ETF, cutting an estimated $1.6M.
- New England Professional Planning Group fully exited GE Vernova in Q3 2026, selling an estimated $247K.
- New England Professional Planning Group's ten largest holdings make up 93% of its $263M portfolio in Q3 2026.
- New England Professional Planning Group opened 1 new position and closed 2 in Q3 2026.
- New England Professional Planning Group's portfolio value fell 1.8% quarter-over-quarter to $263M.
Based on New England Professional Planning Group's 13F filing for Q3 2026, filed 29 Oct 2026.